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THE RECIPIENTS of renal transplants
have been shown to have a more than
50-fold incidence of lymphoid neoplasms
(Hoover & Fraumeni, 1973). A remarkable
feature of this increased risk is that it is
apparent within a few months of trans-
plantation (Kinlen et al., 1979). This ex-
tremely short induction is quite unlike
that ofhuman tumours that are known to
be caused by chemical or physical carcino-
gens. One possibility is that these lymph-
omas have a viral origin, since carcino-
genic transformation by an already pres-
ent oncogenic virus might not require the
latent period that is normal with chemical
carcinogens. On this hypothesis the
tumours would be analogous to the
polyoma-induced tumours in immuno-
suppressed mice (Law & Ting, 1965). If a
virus is involved in these tumours, it
would seem reasonable to determine
whether they display one of the epi-
demiological features of infectivity,
namely space-time clustering. Particularly
as it was known that individual centres
had observed as many as 4 cases of
lymphoma in their transplant recipients,
the transplant data held by the (now dis-
continued) registry of the American Col-
lege of Surgeons have been examined for
evidence of clustering in time and place of
lymphoid tumours.
The data used in this analysis have been
described elsewhere (Hoover & Fraumeni,
1973). They comprise the information on
renal transplantations notified to the
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Human Renal Transplant Registry of
the American College of Surgeons from
283 participating hospitals in 30 countries.
In addition to identifying and demo-
graphic details about the recipient and
donor, the registry received annual follow-
up details about the recipient. The data
analysed in the present study relate to the
16,869 patients who survived for at least
one month after transplantation in the
period 1951-1977, in all contributing
41,404*2 person-years at risk to the
analysis. The closing date for follow-up
was no later than 1977, when the registry
itselfwas closed, but the exact date varied
according to transplant centre.
Five approaches were used to search for
evidence of clustering. First, in those
centres with at least one lymphoma, the
incidence of such tumours occurring after
the first was compared to the overall
incidence rate. This was also compared to
the incidence of later lymphomas in
centres that recorded 2 lymphomas. In
these analyses, the person-years at risk
were measured from the dates ofdiagnosis
of the first and second lymphomas
respectively.
In the second approach, the periods
covered by the data were divided into 2
approximately equal parts and the inci-
dence oflymphoid tumours determined in
the second period in centres which had
recorded a case in the preceding period.
This incidence rate was then compared to
the rate in the second period in centres
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with no such case in the earlier period.
The division was made at 31 December
1969, as this represented the approximate
median date of transplantation on the file
on which there was some follow-up infor-
mation.
In the third approach, the incidence of
lymphoid tumours was calculated in
patients who might have had direct con-
tact after their own transplantation with
the first transplant patient in a centre to
develop a lymphoma. Patients were in-
cluded in this analysis if the interval from
their transplantation to follow-up (or
death) overlapped that between transplant
and the diagnosis of the (first) lymphoma
in the same centre. For this purpose of
calculating the incidence of lymphoid
tumours in this group, person-years were
contributed to the analysis by eligible
patients who were transplanted before the
index patients only from the transplant
date ofthe index patient with lymphoma.
In the fourth approach the numbers of
centres with 0, 1, 2, 3 or 4 more lymphoma
cases were compared to the numbers ex-
pected if there were no clustering of cases
within centres. These expected numbers
were calculated as follows: it was assumed
that at any time after the transplant all
patients had the same risk per month of
developing a lymphoma. This risk was
taken as the total number of lymphomas
in all centres divided by the total number
ofpatient-months at risk. The probability
of a particular patient developing a
lymphoma was obtained by multiplying
this risk by the number of months he was
followed after the transplant. If these
probabilities are computed for every
patient treated at a centre the probabili-
ties that the centre will have 0, 1, 2, 3 or
more than 3 patients with a lymphoma
could be derived. Summation of these
probabilities for all centres gave the ex-
pected numbers of centres with 0, 1, 2, 3
or more than 3 cases.
Lastly, the Knox method of testing for
the presence of space-time clustering was
applied to the data. In this test, the num-
ber ofpairs of cases that are close in space
and time is compared to the number that
would be expected if there was no inter-
action between occurrence in space and
time. One of the problems of the method
is in deciding what to regard as closeness,
and it is important to make this decision
independently of the findings. In this
study, any cases in which the transplanta-
tion was made in the same centre have
been regarded as close in space. Closeness
in time is less straightforward, but since
lymphomas in transplant patients are
striking for their short induction period,
3 months might be proposed as a reason-
able measure of closeness in time. In fact,
a series of different intervals have been
used, from 1 to 9 months.
Among the patients of the 283 trans-
plant centres, there were 54 who were
recorded as developing a lymphoid tumour
(including microgliomas). The overall in-
cidence of lymphomas in all centres com-
bined was 1 3/1000/year. These 54
patients belonged to 39 different centres.
The annual incidence of subsequent
lymphomas in those 39 centres was found
to be 1 48 per 1000 (giving a ratio to the
overall rate of 1.1). The corresponding
rate in centres in which 2 such tumours
were diagnosed was 1-89 per 1000 in the
period after the diagnosis of a second
lymphoma, a ratio to the overall rate of
1-5. None of the differences between the
rates is statistically significant. The inci-
dence oflymphomas in transplant patients
showed evidence of a decline, the rate
being 2.25/1000 before 1970 and 112 after.
However, adjusting for the secular trend
across four periods (before 1965, 1965-69,
1970-74, and after 1974) had no significant
effect on the above ratios, 1 1 becoming
1-2 and 1-5 becoming 1*6.
Since the risk of lymphomas in trans-
plant patients is higher after a cadaver
graft than with a living donor, the possi-
bility was investigated that the high rate
in certain centres might reflect a greater
use ofcadaver kidneys as grafts. However,
the fact that 63% of patients in centres
with one or no lymphoma case had cadaver
grafts compared to 67% ofthose in centres
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TABLE I.-Distribution oftransplant centres
with cases of lymphoid tumours in two
periods
The 10 centres with a lymphoid
tumour before 1970
The 273 centres with no lymphoid
tumour before 1970
No. of centres
with a case of
lymphoid
tumour in
1970 or
after
(No. ofcases)
3 (4)
29 (35)
with two or more such cases indicated that
this could not explain the findings.
Using the second approach described in
the preceding section, 10 centres were
found to have had at least one lymphoma
in a transplant patient before 31 Decem-
ber 1969, this being the approximate
median transplant date ofall thefollowed-
up transplant cases on the file. As shown
in Table I, 3 of these 10 centres had had
no case in the first period, compared to 29
of the 273 centres that had no case in the
first period. These cases indicated an
average annual incidence of lymphoid
neoplasms in the second period of 0.79/
1000 in centres with such a tumour in the
preceding period, compared to a rate of
1.14/1000 in those centres without a case
in the earlier period.
In the third approach, in those centres
with a lymphoid tumour the incidence of
these tumours was calculated in those
patients who could have had direct con-
tact (after their own transplant) with the
first patient in these centres to develop
this neoplasm. In calculating the person-
years at risk for this estimation, the
possible contact (i.e. the overlapping
period) had to occur between the dates of
transplantation and of diagnosis of the
tumour. The group with the possibility of
direct contact with a patient in the postu-
lated induction period for a lymphoid
tumour contributed a total of 89,698
person-years and yielded 12 lymphomas,
representing an annual incidence rate of
1.34/1000. This was similar to the overall
annual incidence in all transplant centres
combined of 1.3/1000.
In the fourth approach the expected
numbers of centres with 0, 1, 2, 3 or 4
cases of lymphoma were calculated and
compared with the actual distribution of
cases between centres. The results are
shown in Table II and do not suggest any
TABLE II.-Observed and expected numbers
of centres with different numbers of
lymphoma cases
No. of centres
No. ofcases A
per centre Obs. Exp.
0 244 242x7
1 31 30-7
2 3 6-8
3 3 19
4 or more* 2 0 9
Total 283 283 0
* No centre had more than 4 cases.
excess of lymphoma in particular trans-
plant centres.
Lastly, the Knox method of testing for
space-time clustering was applied bearing
in mind its limitations in the presence ofa
changingpopulationoftransplantpatients.
The occurrence of 2 or more cases in the
same centre was regarded as clustering in
space and a series of different time inter-
vals was used to evaluate closeness in time
ofdates oftransplantation. The results are
shown in Table III. For the interval that
maximizes the difference between the
observed and expected numbers, namely
within 4 months, 3 pairs of patients with
lymphoma were observed, compared to
1-56 expected, a difference that is not
statistically significant (P=0-21). Simi-
larly no significant differences were de-
tected when the procedure was repeated
using the date of diagnosis of the lymph-
oma instead ofthe date oftransplantation.
Although most ofthe transplant centres
contributing to the International Registry
of the American College of Surgeons did
not record a single case of lymphoma in
any oftheir patients, a few centres had up
to 4 cases. The finding that centres with
one lymphoma in a transplant recipient
subsequently had a higher annual inci-
dence of lymphomas (1-48/1000) than the
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TABLE III.-Clustering of transplant dates in lymphoma cases in the same transplant
centre
Interval between cases
1 month 2 months 3 months 4 months 5 months 6 months 9 months All
No. of pairs: or less or less or less or less or less or less or less intervals
Obs. 0 1 2 3 3 4 5 24
Exp. 0 55 0 77 1-17 1.36* 1-93 2-25 3-62 24
Obs./exp. 1-2 1-7 2*2 1.5 1-7 1-3 1.0
Total pairs
(all centres) 33 46 70 81 115 134 216 1431
* Calculated as follows: 81 x 24 1-36. 1431-
overall rate (1 3) and that those centres
with two lymphomas had a still higher
rate subsequently (1.89) encouraged us to
take further a search for evidence of a
transmissible agent in the aetiology ofthis
unusual neoplasm. However, the lack of
evidence of space-time clustering, or of a
higher incidence in transplant patients
who could have had direct contact with
lymphoma patients in the induction
period, weighs against the initial finding
being due to a transmissible agent. Chance
would seem the most likely explanation
for the relatively small observed differ-
ences in incidence, though it is possible
that the apparent slight predilection of
lymphomas for certain transplant centres
is due to characteristics of the centres in
question. Even ifthis is the case, however,
we have no means at this stage of dis-
tinguishing between the effects ofpossible
differences between the centres in diag-
nostic thoroughness, notification to the
registry or in patient management, any of
which might contribute to the observed
differences which are slight and statistic-
ally not significant.
Failure to find convincing evidence
of clustering of lymphoid tumours in
transplant patients would not, of course,
exclude the possibility of viral origin
for these tumours. Even with a viral
origin it would only be reasonable to
expect clustering of these tumours if
transplantation was important not only in
causing malignant transformation, but
also in encouraging patient-to-patient
transmission of the infection iteself. Lack
of evidence of clustering of lymphomas in
transplant patients would be consistent,
for example, with an origin in latent viral
infection contracted earlier in life.
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